$KNRX

KNOREX LTD.

Insider trades
0
0
1

No SEC Form 4 filings for $KNRX in the last 30 days.

See all $KNRX insider activity →

Knorex Ltd. Replaces Kreit & Chiu With Assentsure PAC as Independent Auditor

Knorex Ltd.'s audit committee replaced Kreit & Chiu CPA LLP with Assentsure PAC as its independent auditor on November 26, 2025. The company stated there were no disagreements or reportable events with the former auditor, and no prior consultations with the new auditor, indicating a routine change. This transition for the Singapore-headquartered foreign private issuer was reported in a Form 6-K on December 31, 2025.

Knorex Discloses Widening Shareholders’ Deficit in Mid-2025 Unaudited Results

Knorex Ltd. (KNRX) filed unaudited financials for the six months ended June 30, 2025, revealing a significant deterioration in its financial health. The company's total assets decreased, short-term debt increased, and its shareholders' deficit widened to $8.8 million, indicating mounting leverage and ongoing losses. Investors and creditors are likely to monitor these figures closely due to heightened balance sheet risk.

KNRX sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning KNRX (KNOREX LTD.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent KNRX coverage spans financial news and corporate actions.

What's driving KNRX

  • Going‑concern language signals serious financial distress.

    benzinga.com · Aug 24, 2026

  • The replacement of the independent auditor by Knorex Ltd. appears to be a routine governance update with minimal immediate impact on stock performance.

    TipRanks · Jan 1, 2026

  • Knorex Ltd. reports a widened shareholders' deficit, increased leverage, and ongoing losses, indicating deteriorating financial health. This negative financial trend could pressure the stock price downward in the near term.

    TipRanks · Jan 1, 2026

  • Knorex's robust Q4 ad spend suggests a positive shift in business momentum, potentially leading to improved financial performance in 2026.

    Investing.com Canada · Jan 1, 2026

alphai scores every news story that mentions KNRX with an AI model for sentiment and relevance, and aggregates insider trades from KNOREX LTD.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $KNRX

Score
$XPONLow

Nasdaq Down 150 Points; Chicago Fed National Activity Index Drops In July - Expion360 (NASDAQ:XPON), Knor

U.S. stocks were mixed Monday, with the Nasdaq Composite down 150 points. The Chicago Fed National Activity Index fell to -0.08 in July, suggesting economic slowdown. Expion360 (XPON) surged 133% after a $3.425M acquisition and a $9M share offering. CID HoldCo (DAIC) and Sadot Group (SDOT) also rose, while FLZH, RFAI, and KNRX declined.

$KNRXLow

Knorex Ltd. Replaces Kreit & Chiu With Assentsure PAC as Independent Auditor

Knorex Ltd.'s audit committee replaced Kreit & Chiu CPA LLP with Assentsure PAC as its independent auditor on November 26, 2025. The company stated there were no disagreements or reportable events with the former auditor, and no prior consultations with the new auditor, indicating a routine change. This transition for the Singapore-headquartered foreign private issuer was reported in a Form 6-K on December 31, 2025.

$KNRXMed

Knorex Discloses Widening Shareholders’ Deficit in Mid-2025 Unaudited Results

Knorex Ltd. (KNRX) filed unaudited financials for the six months ended June 30, 2025, revealing a significant deterioration in its financial health. The company's total assets decreased, short-term debt increased, and its shareholders' deficit widened to $8.8 million, indicating mounting leverage and ongoing losses. Investors and creditors are likely to monitor these figures closely due to heightened balance sheet risk.

Knorex reports strong q4 ad spend despite first-half revenue decline

Knorex Ltd. reported a strong Q4 in ad spend through its XPO platform, despite a revenue decline in the first half of 2025 due to a major client loss. The AI-driven programmatic advertising platform provider, which recently listed on NYSE American, is now focusing on diversifying its customer base and aggressively investing in sales and marketing to drive accelerated growth in 2026. The company also announced successful client case studies, including a Canadian dental network that saw significant growth and cost reduction using Knorex's platform.

Related tickers